AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Here's what you need to know about the AbbVie-Allergan deal
A Glimpse Inside the Labs at AbbVie’s Bioresearch Center
Cramer’s Mad Dash: AbbVie
A Decade of Impact: AbbVie’s Commitment to Patients and Communities
AbbVie's Nicholas Donoghoe on Innovation in Drug Development Process
Internships at AbbVie: The Experience and Opportunities
Final Trades: Abbvie, Broadcom, Deere
AbbVie acquires Immunogen for $10 bn
AbbVie-Allergan merger is just the beginning of more mergers, says market expert
AbbVie Sees More Than $80 Billion Demand for Bond Sale
AbbVie Shares Tumble After $63 Billion Allergan Deal
AbbVie is buying Botox producer Allergan for about $63 billion
Final Trades: Pfizer, Autodesk, Abbvie and XLV
Final Trades: Abbvie, S&P Global and more
World’s Best-Selling Drug Costs Five Times More In U.S. Than Europe | NBC Nightly News
Final Trades: Goldman Sachs, Taiwan Semi and Abbvie
Final Trades: Abbvie, Goldman Sachs & more
Lightning Round: It's never too late to sell ADT 'it has been an abomination', says Jim Cramer
Unlocking Data Insights with the AbbVie Research Collaborative
Why Do Employees Love Working at AbbVie?
Final Trades: Abbvie, Stryker, Crown Castle, Marathon Petroleum
Is Abbvie Stock a Buy Now!? | Abbvie (ABBV) Stock Analysis!
Abbvie CEO on Allergan acquisition, coronavirus' effect on demand and more
Introduction to AbbVie's Deferred Compensation Plan
AbbVie CEO Richard Gonzalez on the purchase of Allergan
Introducing the AbbVie Research Collaborative
Jim Cramer assesses recent acquisitions in AbbVie and Bristol-Myers
Abbott Labs Spins-Off New Business, AbbVie
Cramer's lightning round: AbbVie stock is a bargain
Working at AbbVie in Ireland – AbbVie Ballytivnan, Sligo
AbbVie buys Allergan for $63 billion
Making Possibilities Real: AbbVie Puts Patients First
Why Investors Are Flocking to the AbbVie Bond Sale
Final Trades: AbbVie, Discovery, the XLF & more
Working at AbbVie in Ireland – AbbVie Cork
Inside the Labs of AbbVie Ludwigshafen
Abbvie shares tumble after CVS drops Humira in favor of biosimilars
Getting to know: AbbVie Inc
Final Trades: Verizon, Abbvie, Gilead Sciences and Arch Capital Group
AbbVie’s Botox faces demand issues as prices soar
2021 AbbVie Possibilities Scholarship Recipients
AbbVie Biologics Ballytivnan Aseptic Fill Finish Line
Final Trades: Abbvie, Goldman Sachs, Charles River & more
AbbVie Contract Manufacturing
Katie Porter PRESSES pharma CEO on increased US prices of two drugs
ABBV Stock | AbbVie Q2 2020 Earnings Call
AbbVie Stories – Rewriting the story of a disease takes all of us.
Final Trades: Abbvie, Thermo Fisher & more
Working at AbbVie in Ireland – The Passion of Our People
Abbvie Stock is near a 52 Week Low! | Abbvie (ABBV) Stock Analysis!
AbbVie $ABBV Q1 2023 Earnings Call
Celebrating Women at AbbVie
Final Trades: Abbvie, CVS, Small caps & more
AbbVie in HCV – Determined to Help End HCV Together
FDA Issues Warning for AbbVie and JAK inhibitor drugs